Document is current
Any future updates will be listed below
-
Authors
Szilagyi, Peter G. https://orcid.org/0000-0003-1951-0644
Albertin, Christina S.
Casillas, Alejandra
Valderrama, Rebecca
Duru, O. Kenrik
Ong, Michael K
Vangala, Sitaram
Tseng, Chi-Hong
Humiston, Sharon G.
Evans, Sharon
Sloyan, Michael
Bogard, Jonathan E.
Fox, Craig R.
Lerner, Carlos
-
Funding
Funding for this research was provided by:
national institute of allergy and infectious diseases (1R01AI135029-01)
national center for advancing translational sciences (1R01AI135029-01)
- License Information
-
More Information
Article History
Received: 15 June 2021
Accepted: 30 June 2021
First Online: 1 September 2021
Declaration
:
: The UCLA IRB approved this study.
: Dr. Humiston is a consultant to Sanofi Pasteur. Dr. Humiston’s employer gets grant money for her work sponsored by the Pediatric Infectious Diseases Society Foundation, a not-for-profit organization. PIDS is funded for the project through unrestricted joint educational grants from Sanofi Pasteur US, Merck & Co., Inc., Pfizer, Inc., GlaxoSmithKline, and Seqirus USA, Inc.All other authors have no conflicts of interest to report.
: The funding agency had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
